Steendijk P, Baan J, Van der Velde E T, Baan J
Leiden University Medical Centre, Department of Cardiology, The Netherlands.
J Am Coll Cardiol. 1998 Sep;32(3):816-26. doi: 10.1016/s0735-1097(98)00313-1.
In this study we quantified the effects of a critical coronary stenosis on global systolic function using pressure-volume relations at baseline and during incremental dobutamine stress.
The effects of coronary stenosis have previously been analyzed mainly in terms of regional (dys)function. Global hemodynamics are generally considered normal until coronary flow is substantially reduced. However, pressure-volume analysis might reveal mechanisms not fully exposed by potentially load-dependent single-beat parameters. Moreover, no systematic analysis by pressure-volume relations of the effects of dobutamine over a wide dose range has previously been presented.
In 14 dogs left ventricular volume and pressure were measured by conductance and micromanometer catheters, and left circumflex coronary flow by Doppler probes. Measurements in control and with left circumflex stenosis were performed at baseline and at five levels of dobutamine (2.5 to 20 microg/kg/min). The end-systolic pressure-volume relation (ESPVR) dP/dtMAX vs. end-diastolic volume (dP/dtMAX - V(ED)) and the relation between stroke work and end-diastolic volume (preload recruitable stroke work [PRSW]) were derived from data obtained during gradual caval occlusion.
In control, dobutamine gradually increased heart rate up to 20 microg/kg/min, the inotropic effect blunted at 15 microg/kg/min. With stenosis, the chronotropic effect was similar, however, contractile state was optimal at approximately 10 microg/kg/min and tended to go down at higher levels. At baseline, the positions of ESPVR and PRSW, but not of dP/dtMAX - V(ED), showed a significant decrease in function with stenosis. No differences between control and stenosis were present at 2.5 microg/kg/min; the differences were largest at 15 microg/kg/min.
Pressure-volume relations and incremental dobutamine may be used to quantify the effects of critical coronary stenosis. The positions of these relations are more consistent and more useful indices than the slopes. The positions of the ESPVR and PRSW show a reduced systolic function at baseline, normalization at 2.5 microg/kg/min and a consistent significant difference between control and stenosis at dobutamine levels of 5 microg/kg/min and higher.
在本研究中,我们利用基线及递增多巴酚丁胺负荷试验时的压力-容积关系,量化严重冠状动脉狭窄对整体收缩功能的影响。
冠状动脉狭窄的影响此前主要从局部(功能异常)方面进行分析。在冠状动脉血流显著减少之前,一般认为整体血流动力学是正常的。然而,压力-容积分析可能揭示一些潜在的与负荷相关的单搏参数未完全暴露的机制。此外,此前尚未有通过压力-容积关系对多巴酚丁胺在广泛剂量范围内的影响进行系统分析的报道。
对14只犬,通过电导和微测压导管测量左心室容积和压力,用多普勒探头测量左旋支冠状动脉血流。在基线以及五个多巴酚丁胺水平(2.5至20微克/千克/分钟)下,分别在对照状态和左旋支狭窄状态下进行测量。收缩末期压力-容积关系(ESPVR)、dp/dtMAX与舒张末期容积的关系(dp/dtMAX - V(ED))以及每搏功与舒张末期容积的关系(可通过前负荷增加的每搏功[PRSW]),均从逐步阻断腔静脉过程中获得的数据推导得出。
在对照状态下,多巴酚丁胺使心率逐渐增加,直至20微克/千克/分钟,在15微克/千克/分钟时变力作用减弱。存在狭窄时,变时作用相似,但收缩状态在约10微克/千克/分钟时最佳,在更高剂量时趋于下降。在基线时,ESPVR和PRSW的位置,但不包括dp/dtMAX - V(ED)的位置,显示出狭窄导致功能显著下降。在2.5微克/千克/分钟时,对照与狭窄之间无差异;差异在15微克/千克/分钟时最大。
压力-容积关系和递增多巴酚丁胺可用于量化严重冠状动脉狭窄的影响。这些关系的位置比斜率更一致且更有用。ESPVR和PRSW的位置在基线时显示收缩功能降低,在2.5微克/千克/分钟时恢复正常,在多巴酚丁胺水平为5微克/千克/分钟及更高时,对照与狭窄之间存在一致的显著差异。